Press release
Traumatic Brain Injury - Pipeline Review, 2017
Traumatic brain injury happens when an external mechanical force causes brain damage. Traumatic brain injury usually results from a violent blow or jolt to the head or body. Symptoms include headache, dizziness, nausea or vomiting, mood changes, fatigue or drowsiness, difficulty sleeping and memory or concentration problems. Risk factor includes age. Certain types of traumatic brain injury increase the risk of developing Alzheimer's disease and coordination problems.
Report Highlights
Publisher's Pharmaceutical and Healthcare latest pipeline guide Traumatic Brain Injury - Pipeline Review, H1 2017, provides comprehensive information on the therapeutics under development for Traumatic Brain Injury (Central Nervous System), complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The guide covers the descriptive pharmacological action of the therapeutics, its complete research and development history and latest news and press releases.
Request Sample Report@ http://www.reportsweb.com/inquiry&RW0001689371/sample
The Traumatic Brain Injury (Central Nervous System) pipeline guide also reviews of key players involved in therapeutic development for Traumatic Brain Injury and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies /Universities /Institutes, the molecules developed by Companies in Phase III, Phase II, Phase I, IND/CTA Filed, Preclinical and Discovery stages are 1, 7, 3, 1, 56 and 10 respectively. Similarly, the Universities portfolio in Preclinical and Discovery stages comprises 11 and 1 molecules, respectively.
Traumatic Brain Injury (Central Nervous System) pipeline guide helps in identifying and tracking emerging players in the market and their portfolios, enhances decision making capabilities and helps to create effective counter strategies to gain competitive advantage. The guide is built using data and information sourced from Publisher’s proprietary databases, company/university websites, clinical trial registries, conferences, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources. Additionally, various dynamic tracking processes ensure that the most recent developments are captured on a real time basis.
Note: Certain content / sections in the pipeline guide may be removed or altered based on the availability and relevance of data.
Inquiry for Buying@ http://www.reportsweb.com/inquiry&RW0001689371/buying
List of Tables
Number of Products under Development for Traumatic Brain Injury, H1 2017
Number of Products under Development by Companies, H1 2017
Number of Products under Development by Companies, H1 2017 (Contd..1), H1 2017
Number of Products under Development by Companies, H1 2017 (Contd..2), H1 2017
Number of Products under Development by Companies, H1 2017 (Contd..3), H1 2017
Number of Products under Development by Universities/Institutes, H1 2017
Products under Development by Companies, H1 2017
Products under Development by Companies, H1 2017 (Contd..1), H1 2017
Products under Development by Companies, H1 2017 (Contd..2), H1 2017
Products under Development by Companies, H1 2017 (Contd..3), H1 2017
Products under Development by Universities/Institutes, H1 2017
Number of Products by Stage and Target, H1 2017
Number of Products by Stage and Target, H1 2017 (Contd..1), H1 2017
Number of Products by Stage and Target, H1 2017 (Contd..2), H1 2017
Number of Products by Stage and Mechanism of Action, H1 2017
Number of Products by Stage and Mechanism of Action, H1 2017 (Contd..1), H1 2017
Number of Products by Stage and Mechanism of Action, H1 2017 (Contd..2), H1 2017
Number of Products by Stage and Route of Administration, H1 2017
Number of Products by Stage and Molecule Type, H1 2017
Traumatic Brain Injury - Pipeline by ALSP Inc, H1 2017
Traumatic Brain Injury - Pipeline by Amarantus Bioscience Holdings Inc, H1 2017
Traumatic Brain Injury - Pipeline by Apollo Endosurgery Inc, H1 2017
Traumatic Brain Injury - Pipeline by Athersys Inc, H1 2017
Traumatic Brain Injury - Pipeline by Beech Tree Labs Inc, H1 2017
Traumatic Brain Injury - Pipeline by Cognosci Inc, H1 2017
Traumatic Brain Injury - Pipeline by Eustralis Pharmaceuticals Ltd, H1 2017
Traumatic Brain Injury - Pipeline by Intellect Neurosciences Inc, H1 2017
Traumatic Brain Injury - Pipeline by International Stem Cell Corp, H1 2017
Traumatic Brain Injury - Pipeline by Ischemix Inc, H1 2017
Traumatic Brain Injury - Pipeline by Karyopharm Therapeutics Inc, H1 2017
Traumatic Brain Injury - Pipeline by Kyorin Pharmaceutical Co Ltd, H1 2017
Traumatic Brain Injury - Pipeline by Levolta Pharmaceuticals Inc, H1 2017
Traumatic Brain Injury - Pipeline by Lixte Biotechnology Holdings Inc, H1 2017
Traumatic Brain Injury - Pipeline by MandalMed Inc, H1 2017
Traumatic Brain Injury - Pipeline by Mapreg SAS, H1 2017
Traumatic Brain Injury - Pipeline by Neuralstem Inc, H1 2017
Traumatic Brain Injury - Pipeline by Neuren Pharmaceuticals Ltd, H1 2017
Traumatic Brain Injury - Pipeline by Neurofx Inc, H1 2017
Traumatic Brain Injury - Pipeline by NeuroNascent Inc, H1 2017
Traumatic Brain Injury - Pipeline by NeuroVive Pharmaceutical AB, H1 2017
Traumatic Brain Injury - Pipeline by New World Laboratories Inc, H1 2017
Traumatic Brain Injury - Pipeline by NuvOx Pharma LLC, H1 2017
Traumatic Brain Injury - Pipeline by Omeros Corp, H1 2017
Traumatic Brain Injury - Pipeline by Oxeia Biopharmaceuticals Inc, H1 2017
Traumatic Brain Injury - Pipeline by PharmatrophiX Inc, H1 2017
Traumatic Brain Injury - Pipeline by Phylogica Ltd, H1 2017
Traumatic Brain Injury - Pipeline by Prevacus Inc, H1 2017
Traumatic Brain Injury - Pipeline by QR Pharma Inc, H1 2017
Traumatic Brain Injury - Pipeline by RegeneRx Biopharmaceuticals Inc, H1 2017
Traumatic Brain Injury - Pipeline by Remedy Pharmaceuticals Inc, H1 2017
Traumatic Brain Injury - Pipeline by Sage Therapeutics Inc, H1 2017
Traumatic Brain Injury - Pipeline by SanBio Inc, H1 2017
Traumatic Brain Injury - Pipeline by STATegics Inc, H1 2017
Traumatic Brain Injury - Pipeline by Stemedica Cell Technologies Inc, H1 2017
Traumatic Brain Injury - Pipeline by SynZyme Technologies LLC, H1 2017
Traumatic Brain Injury - Pipeline by Tetra Discovery Partners LLC, H1 2017
Traumatic Brain Injury - Pipeline by Thera Neuropharma Inc, H1 2017
Traumatic Brain Injury - Pipeline by vasopharm GmbH, H1 2017
Traumatic Brain Injury - Pipeline by VG Life Sciences Inc, H1 2017
Traumatic Brain Injury - Dormant Projects, H1 2017
Traumatic Brain Injury - Dormant Projects, H1 2017 (Contd..1), H1 2017
Traumatic Brain Injury - Dormant Projects, H1 2017 (Contd..2), H1 2017
Traumatic Brain Injury - Discontinued Products, H1 2017
Find More Information@ http://www.reportsweb.com/traumatic-brain-injury-pipeline-review-h1-2017
List of Figures
Number of Products under Development for Traumatic Brain Injury, H1 2017
Number of Products under Development by Companies, H1 2017
Number of Products under Development by Universities/Institutes, H1 2017
Number of Products by Top 10 Targets, H1 2017
Number of Products by Stage and Top 10 Targets, H1 2017
Number of Products by Top 10 Mechanism of Actions, H1 2017
Number of Products by Stage and Top 10 Mechanism of Actions, H1 2017
Number of Products by Top 10 Routes of Administration, H1 2017
Number of Products by Stage and Top 10 Routes of Administration, H1 2017
Number of Products by Top 10 Molecule Types, H1 2017
Number of Products by Stage and Top 10 Molecule Types, H1 2017
About ReportsWeb:
ReportsWeb.com is a one stop shop of market research reports and solutions to various companies across the globe. We help our clients in their decision support system by helping them choose most relevant and cost effective research reports and solutions from various publishers. We provide best in class customer service and our customer support team is always available to help you on your research queries.
Contact Us:
Call: +1-646-491-9876
Email: sales@reportsweb.com
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Traumatic Brain Injury - Pipeline Review, 2017 here
News-ID: 744366 • Views: …
More Releases from ReportsWeb
North America: Smart Airport Market Overall Study Report 2020-2026| Amadeus IT G …
The "Global North America Smart Airport Market: 2020" Industry Report is a professional and in-depth study on the current state of the North America Smart Airport Market by PMR. The North America Smart Airport market is supposed to demonstrate a considerable growth during the forecast period of 2020 - 2026. The company profiles of all the key players and brands that are dominating the market have been given in this…
Marine Biotechnology Market Future Forecast 2018-2026 by Leading Companies such …
ReportsWeb.com has announced the addition of the “Marine Biotechnology-Global Market Outlook 2017-2026” The report classifies the global Marine Biotechnology Market in a precise manner to offer detailed insights about the aspects responsible for augmenting as well as restraining market growth.
According to Publisher, the Global Marine Biotechnology Market is accounted for $3.93 billion in 2017 and is expected to reach $8.74 billion by 2026 growing at a CAGR of 9.3% during…
Anti-Counterfeiting Packaging Market Growth Opportunities and Emerging Trends by …
ReportsWeb.com has announced the addition of the “Anti-Counterfeiting Packaging-Global Market Outlook 2017-2026” The report classifies the global Anti-Counterfeiting Packaging Market in a precise manner to offer detailed insights about the aspects responsible for augmenting as well as restraining market growth.
According to Publisher, the Global Anti-Counterfeiting Packaging Market is accounted for $112.16 billion in 2017 and is expected to reach $427.96 billion by 2026 growing at a CAGR of 16.0% during…
Solar Photovoltaic in Italy Market Outlook to 2030 | Company Profiles (Tozzi Hol …
Solar Photovoltaic (PV) in Italy, Market Outlook to 2030, Update 2018-Capacity, Generation, Investment Trends, Regulations and Company Profiles
Summary
"Solar Photovoltaic (PV) in Italy, Market Outlook to 2030, Update 2018-Capacity, Generation, Investment Trends, Regulations and Company Profiles", is the latest report from Publisher, the industry analysis specialists that offer comprehensive information and understanding of the Solar Photovoltaic (PV) market in Italy.
The report provides in depth analysis on global renewable power market and…
More Releases for Traumatic
The increase in the prevalence of brain traumatic injuries is projected to boost …
The research report "Traumatic Brain Injury Treatment Market: By Treatment Type (Drugs, Surgery), By Route of Administration (Oral, Parenteral), By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online Pharmacies), and Geography - Global/Region/Country Forecast to 2028. The traumatic brain injury treatment market size was valued at USD 3.03 billion in 2021 is and anticipated to grow at 8.2% CAGR rate over the forecast period 2022-2028.
Glance our 200 slides market research and…
Global Traumatic Brain Injury Market - Forecasts to 2026
According to a new market research report published by Global Market Estimates, the Global Traumatic Brain Injury Market is projected to grow from USD 3.1 billion in 2021 to USD 4.5 billion by 2026 at CAGR of 8.0%. The increasing prevalence of traumatic brain injuries (TBIs), rising preference for minimally invasive procedures, and increasing awareness regarding early diagnosis of brain injuries are the major factors expected to fuel the market…
Traumatic Acid Market: Competitive Dynamics & Global Outlook 2025
LP INFORMATION recently released a research report on the Traumatic Acid analysis, which studies the Traumatic Acid industry coverage, current market competitive status, and market outlook and forecast by 2025.
Global “Traumatic Acid Market 2020-2025” Research Report categorizes the global Traumatic Acid by key players, product type, applications and regions,etc. The report also covers the latest industry data, key players analysis, market share, growth rate, opportunities…
Chronic Traumatic Encephalopathy (CTE) - Pipeline Review, H2 2018 - ResearchByMa …
"Chronic Traumatic Encephalopathy (CTE) - Pipeline Review, H2 2018", provides an overview of the Chronic Traumatic Encephalopathy (CTE) (Central Nervous System) pipeline landscape.
Chronic Traumatic Encephalopathy (CTE) is a degenerative brain disease found in athletes, military veterans, and others with a history of repetitive brain trauma. Symptoms include loss of consciousness, headache, drowsiness, convulsions and slurred speech, nausea or vomiting and unusual behavior. Risk factors include repeated exposure to traumatic brain…
Traumatic Brain Injuries Treatment Market Intelligence with Competitive Landscap …
Each year traumatic brain injuries (TBI) contribute a substantial number of cases worldwide. TBI can be defined as an injury to the brain resulting from externally inflicted trauma resulting in damage to the brain cells and blood vessels. The signs and symptoms of TBI may appear soon after the head trauma or may sometimes take several days to weeks to appear. TBI can be categorized as mild, moderate and severe…
Traumatic Brain Injury(TBI) - Pipeline Insights, 201
Market Research Hub (MRH) has recently publicized a new study to its vast repository, which is titled as “Traumatic Brain Injury(TBI) - Pipeline Insights, 2017”. DelveInsights, Traumatic Brain Injury-Pipeline Insights, 2017, report provides comprehensive insights about pipeline drugs across this indication.
Request For Sample Report@ http://www.marketresearchhub.com/enquiry.php?type=S&repid=1214134
Key objective of the report is to establish the understanding for all the pipeline drugs that fall under Traumatic Brain Injury. This report provides information on the…
